Boc-MLF

CAS No. 67247-12-5

Boc-MLF ( —— )

Catalog No. M22359 CAS No. 67247-12-5

Antagonist of formyl peptide receptor 1 (FPR1). Reduces superoxide production induced by fMLF with an EC50 of 0.63 μM. Almost completely blocks fMLF-stimulated primary granule exocytosis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 203 In Stock
5MG 312 In Stock
10MG 467 In Stock
25MG 759 In Stock
50MG 1044 In Stock
100MG 1413 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Boc-MLF
  • Note
    Research use only, not for human use.
  • Brief Description
    Antagonist of formyl peptide receptor 1 (FPR1). Reduces superoxide production induced by fMLF with an EC50 of 0.63 μM. Almost completely blocks fMLF-stimulated primary granule exocytosis.
  • Description
    Antagonist of formyl peptide receptor 1 (FPR1). Reduces superoxide production induced by fMLF with an EC50 of 0.63 μM. Almost completely blocks fMLF-stimulated primary granule exocytosis.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    FPR1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    67247-12-5
  • Formula Weight
    509.66
  • Molecular Formula
    C25H39N3O6S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:2 mg/mL
  • SMILES
    O=C([C@@H](NC([C@@H](NC(OC(C)(C)C)=O)CCSC)=O)CC(C)C)N[C@H]([C@@](O)=O)CC1=CC=CC=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Boxio et al (2005) The immunostimulatory peptide WKYMVm-NH2 activates bone marrow mouse neutrophils via multiple signal transduction pathways. Scand.J.Immunol. 62 140 PMID:
molnova catalog
related products
  • Clinopodic acid E

    The roots of Salvia miltiorrhiza Bge.

  • Tartrazine

    Tartrazine is a food additive that belongs to a class of artificial dyes and contains an azo group.

  • Tubeimoside III

    Tubeimoside III has anti-inflammatory anti-tumor and anti-tumorigenic activities stronger than those of tubeimoside II.